Research Impact
July 16, 2025
Hannah Regan Associate Director for Research and Evaluation, Interim Executive Director Flora Stone Mather Center for Women Area of Focus: Evaluative research, gender, sexuality, media and technology As students’ needs and experiences rapidly evolve, Hannah Regan is working to ensure…
July 15, 2025
Paving the way for breakthroughs in early detection and life-saving treatments
July 10, 2025
A Northeast Ohio consortium of universities, state and regional economic development organizations and manufacturers led by Case Western Reserve University has been selected among 29 semifinalists competing for a $160 million U.S. National Science Foundation (NSF) initiative to drive economic…
July 09, 2025
Case Western Reserve University researcher receives prestigious NSF Award for ‘programmable’ nanoparticles
July 08, 2025
Research aims to guide decision-makers on real-world effects of artificial intelligence on American workers
July 07, 2025
Epilepsy self-management program shows promise to control seizures, improve mood and quality of life
Epilepsy is among the most common neurological conditions, marked by unpredictable seizures, accidents and injuries, reduced quality of life, stigma and—in the worst case—premature death. But a program—developed over several years by a Case Western Reserve University-led research team—that…
July 02, 2025
Kylie Meyer is an Assistant Professor at the Frances Payne Bolton School of Nursing. Area of Focus: Family caregiving, psychoeducational intervention, health and aging policy, caregiving relationships and financial well-being, gerontology, artificial intelligence Nearly 48 million Americans…
June 26, 2025
Gary Schwartz leads a top cancer center, but still sees patients and meets regularly with community members as he pursues a clear vision: 'Everybody should have access to the latest advances in cancer medicine'
June 26, 2025
New lymphoma T-cell therapy, made in less than a day, shows promising results with fewer side effects
June 25, 2025
Researchers at the Case Western Reserve School of Medicine have found that semaglutide, a popular diabetes and weight-loss drug, may lower the risk of dementia in people with type 2 diabetes (T2D). Dementia, a condition that slowly makes it harder for people to remember things and think clearly,…